Safety of New Formulation of Glatiramer Acetate

Summary

The purpose of this study is to compare pain associated with injections and injection-site reactions of the approved formulation of Glatiramer Acetate (GA) versus investigational formulation of GA. In addition, the investigators will evaluate the side effects of the two formulations of GA.

Timeline

Start

2009-07

Primary completion

2009-09

Completion

2009-11

Drugs

Indications